NextCure Inc (NASDAQ:NXTC)

3.48
Delayed Data
As of May 16
 -0.06 / -1.69%
Today’s Change
3.25
Today|||52-Week Range
9.18
-42.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$97.4M

Company Description

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Contact Information

NextCure, Inc.
9000 Virginia Manor Road
Beltsville Maryland 20705
P:(240) 399-4900
Investor Relations:

Employees

Shareholders

Other institutional22.10%
Individual stakeholders12.28%
Mutual fund holders10.71%

Top Executives

Michael S. RichmanPresident, Chief Executive Officer & Director
Timothy MayerChief Operating Officer
Steven P. CobournChief Financial Officer
Solomon LangermannChief Scientific Officer
Han MyintChief Medical Officer